Scientific Evidence for Different Options for GDM Screening and Management: Controversies and Review of the Literature

Claudia Caissutti, Vincenzo Berghella, Claudia Caissutti, Vincenzo Berghella

Abstract

Background. Gestational diabetes (GDM) affects up to 7% of pregnant women and is associated with several maternal and perinatal morbidities. International organizations suggest several different recommendations regarding how to screen and to manage GDM. Objective. We aimed to analyze the most important and employed guidelines about screening and management of GDM and we investigated existing related literature. Results. We found several different criteria for screening for GDM, for monitoring GDM, and for starting pharmacological therapy. When using IADPSG criteria, GDM rate increased, perinatal outcomes improved, and screening became cost-effective. Compared to no treatment, treatment of women meeting criteria for GDM by IADPSG criteria but not by other less strict criteria has limited evidence for an effect on adverse pregnancy outcomes.

References

    1. Mackeen A. D., Lott M. Gestational diabetes. In: Berghella V., editor. Maternal-Fetal Evidence Based Guidelines. 3rd. chapter 5. CRC Press; 2017.
    1. Kim C., Newton K. M., Knopp R. H. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25(10):1862–1868. doi: 10.2337/diacare.25.10.1862.
    1. Di Mascio D., Magro-Malosso E. R., Saccone G., Marhefka G. D., Berghella V. Exercise during pregnancy in normal-weight women and risk of preterm birth: A systematic review and meta-analysis of randomized controlled trials. American Journal of Obstetrics and Gynecology. 2016 doi: 10.1016/j.ajog.2016.06.014.
    1. Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 137: Gestational diabetes mellitus. Obstetrics & Gynecology. 2013;122, article 406
    1. Hod M., Kapur A., Sacks D. A., et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. International Journal of Gynecology and Obstetrics. 2015;131(supplement 3):S173–S211. doi: 10.1016/s0020-7292(15)30007-2.
    1. HAPO Study Cooperative Research Group, Metzger B. E., Lowe L. P., et al. Hyperglycemia and adverse pregnancy outcomes. The New England Journal of Medicine. 2008;358, article 1991
    1. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger B. E., Gabbe S. G., et al. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–682. doi: 10.2337/dc09-1848.
    1. World Health Organization. Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy. 2013.
    1. American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2017;40, article S11
    1. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Cheng A. Y. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction. Canadian Journal of Diabetes. 2013;37(supplement 1):S1–S3. doi: 10.1016/j.jcjd.2013.01.009.
    1. NICE. NICE Guidelines. Diabetes in Pregnancy: Management from Preconception to the Postnatal Period. 2015.
    1. Weiss P. A. M., Haeusler M., Kainer F., Purstner P., Haas J. Toward universal criteria for gestational diabetes: relationships between seventy-five and one hundred gram glucose loads and between capillary and venous glucose concentrations. American Journal of Obstetrics and Gynecology. 1998;178(4):830–835. doi: 10.1016/s0002-9378(98)70500-9.
    1. O'Sullivan J. B., Gellis S. S., Tenney B. O. Gestational blood glucose levels in normal and potentially diabetic women related to the birth weight of their infants. Diabetes. 1966;15(7):466–470. doi: 10.2337/diab.15.7.466.
    1. Coustan D. R., Lewis S. B. Insulin therapy for gestational diabetes. Obstetrics and Gynecology. 1978;51(3):306–310. doi: 10.1097/00006250-197803000-00010.
    1. Thompson D. J., Porter K. B., Gunnells D. J., Wagner P. C., Spinnato J. A. Prophylactic insulin in the management of gestational diabetes. Obstetrics and Gynecology. 1990;75(6):960–964.
    1. Crowther C. A., Hiller J. E., Moss J. R., McPhee A. J., Jeffries W. S., Robinson J. S. Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New England Journal of Medicine. 2005;352(24):2477–2486. doi: 10.1056/nejmoa042973.
    1. Landon M. B., Spong C. Y., Thom E., et al. A multicenter, randomized trial of treatment for mild gestational diabetes. New England Journal of Medicine. 2009;361(14):1339–1348. doi: 10.1056/NEJMoa0902430.
    1. Casey B. M., Duryea E. L., Abbassi-Ghanavati M., et al. Glyburide in women with mild gestational diabetes: a randomized controlled trial. Obstetrics and Gynecology. 2015;126(2):303–309. doi: 10.1097/aog.0000000000000967.
    1. Meltzer S. J., Snyder J., Penrod J. R., Nudi M., Morin L. Gestational diabetes mellitus screening and diagnosis: a prospective randomised controlled trial comparing costs of one-step and two-step methods. BJOG. 2010;117(4):407–415. doi: 10.1111/j.1471-0528.2009.02475.x.
    1. Sevket O., Ates S., Uysal O., Molla T., Dansuk R., Kelekci S. To evaluate the prevalence and clinical outcomes using a one-step method versus a two-step method to screen gestational diabetes mellitus. Journal of Maternal-Fetal and Neonatal Medicine. 2014;27(1):36–41. doi: 10.3109/14767058.2013.799656.
    1. Scifres C. M., Abebe K. Z., Jones K. A., et al. Gestational Diabetes Diagnostic Methods (GD2M) pilot randomized trial. Maternal and Child Health Journal. 2014;19(7):1472–1480. doi: 10.1007/s10995-014-1651-4.
    1. Duran A., Sáenz S., Torrejón M. Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: the St. Carlos Gestational Diabetes study. Diabetes Care. 2014;37:2442–2450.
    1. Fuller K. P., Borgida A. F. Gestational diabetes mellitus screening using the one-step versus two-step method in a high-risk practice. Clinical Diabetes. 2014;32(4):148–150. doi: 10.2337/diaclin.32.4.148.
    1. Liu X., Chen Y., Zhou Q., Shi H., Cheng W. W. Utilization of International Association of Diabetes and Pregnancy Study Groups criteria vs. a two-step approach to screening for gestational diabetes mellitus in Chinese women with twin pregnancies. Diabetic Medicine. 2015;32(3):367–373. doi: 10.1111/dme.12636.
    1. Oriot P., Selvais P., Radikov J., et al. Assessing the incidence of gestational diabetes and neonatal outcomes using the IADPSG guidelines in comparison with the Carpenter and Coustan criteria in a Belgian general hospital. Acta Clinica Belgica. 2014;69(1):8–11. doi: 10.1179/0001551213z.0000000004.
    1. Wei Y.-M., Yang H.-X., Zhu W.-W., Yang H.-Y., Li H.-X., Kapur A. Effects of intervention to mild GDM on outcomes. Journal of Maternal-Fetal and Neonatal Medicine. 2015;28(8):928–931. doi: 10.3109/14767058.2014.937697.
    1. Hung T.-H., Hsieh T.-T. The Effects of Implementing the International Association of Diabetes and Pregnancy Study Groups Criteria for diagnosing gestational diabetes on maternal and neonatal outcomes. PLoS ONE. 2015;10(3) doi: 10.1371/journal.pone.0122261.e0122261
    1. Kong J. M., Lim K., Thompson D. M. Evaluation of the International Association of the Diabetes in Pregnancy Study Group New Criteria: gestational diabetes project. Canadian Journal of Diabetes. 2015;39(2):128–132. doi: 10.1016/j.jcjd.2014.09.007.
    1. Assaf-Balut C., Bordiú E., Del Valle L., et al. The impact of switching to the one-step method for GDM diagnosis on the rates of postpartum screening attendance and glucose disorder in women with prior GDM. The San Carlos Gestational Study. Journal of Diabetes and Its Complications. 2016;30(7):1360–1364. doi: 10.1016/j.jdiacomp.2016.04.026.
    1. Klara Feldman R., Tieu R. S., Yasumura L. Gestational diabetes screening the international association of the diabetes and pregnancy study groups compared with carpenter-coustan screening. Obstetrics and Gynecology. 2016;127(1):10–17. doi: 10.1097/AOG.0000000000001132.
    1. Lapolla A., Dalfrà M. G., Ragazzi E., De Cata A. P., Fedele D. New International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recommendations for diagnosing gestational diabetes compared with former criteria. retrospective study on pregnancy outcome. Diabetic Medicine. 2011;28(9):1074–1077. doi: 10.1111/j.1464-5491.2011.03351.x.
    1. Bodmer-Roy S., Morin L., Cousineau J., Rey E. Pregnancy outcomes in women with and without gestational diabetes mellitus according to the international association of the diabetes and pregnancy study groups criteria. Obstetrics and Gynecology. 2012;120(4):746–752. doi: 10.1097/AOG.0b013e31826994ec.
    1. Benhalima K., Hanssens M., Devlieger R., Verhaeghe J., Mathieu C. Analysis of pregnancy outcomes using the new IADPSG recommendation compared with the carpenter and coustan criteria in an area with a low prevalence of gestational diabetes. International Journal of Endocrinology. 2013;2013 doi: 10.1155/2013/248121.248121
    1. Ethridge J. K., Catalano P. M., Waters T. P. Perinatal outcomes associated with the diagnosis of gestational diabetes made by the international association of the diabetes and pregnancy study groups criteria. Obstetrics and Gynecology. 2014;124(3):571–578. doi: 10.1097/AOG.0000000000000412.
    1. Liao S., Mei J., Song W., et al. The impact of the International Association of Diabetes and Pregnancy Study Groups (IADPSG) fasting glucose diagnostic criterion on the prevalence and outcomes of gestational diabetes mellitus in Han Chinese women. Diabetic Medicine. 2014;31(3):341–351. doi: 10.1111/dme.12349.
    1. Mayo K., Melamed N., Vandenberghe H., Berger H. The impact of adoption of the International Association of Diabetes in Pregnancy Study Group criteria for the screening and diagnosis of gestational diabetes. American Journal of Obstetrics and Gynecology. 2015;212(2):224–224.e9. doi: 10.1016/j.ajog.2014.08.027.
    1. Meek C. L., Lewis H. B., Patient C., Murphy H. R., Simmons D. Diagnosis of gestational diabetes mellitus: falling through the net. Diabetologia. 2015;58(9):2003–2012. doi: 10.1007/s00125-015-3647-z.
    1. Tward C., Barrett J., Berger H., et al. Does gestational diabetes affect fetal growth and pregnancy outcome in twin pregnancies? American Journal of Obstetrics and Gynecology. 2016;214(5):653.e1–653.e8. doi: 10.1016/j.ajog.2015.11.006.
    1. Garner P., Okun N., Keely E., et al. A randomized controlled trial of strict glycemic control and tertiary level obstetric care versus routine obstetric care in the management of gestational diabetes: a pilot study. American Journal of Obstetrics and Gynecology. 1997;177(1):190–195. doi: 10.1016/s0002-9378(97)70461-7.
    1. Langer O., Conway D. L., Berkus M. D., Xenakis E. M.-J., Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. New England Journal of Medicine. 2000;343(16):1134–1138. doi: 10.1056/NEJM200010193431601.
    1. Mecacci F., Carignani L., Cioni R., et al. Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant women. European Journal of Obstetrics Gynecology and Reproductive Biology. 2003;111(1):19–24. doi: 10.1016/s0301-2115(03)00157-x.
    1. Schaefer-Graf U. M., Kjos S. L., Fauzan O. H., et al. A randomized trial evaluating a predominately fetal growth-based strategy to guide management of gestational diabetes in Caucasian women. Diabetes Care. 2004;27(2):297–302. doi: 10.2337/diacare.27.2.297.
    1. Anjalakshi C., Balaji V., Balaji M. S., Seshiah V. A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women. Diabetes Research and Clinical Practice. 2007;76(3):474–475. doi: 10.1016/j.diabres.2006.09.031.
    1. Ijäs H., Vääräsmäki M., Morin-Papunen L., et al. Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. BJOG. 2011;118(7):880–885. doi: 10.1111/j.1471-0528.2010.02763.x.
    1. Balaji V., Balaji M. S., Alexander C., et al. Premixed insulin aspart 30 (BIAsp 30) versus premixed human insulin 30 (BHI 30) in gestational diabetes mellitus: a randomized open-label controlled study. Gynecological Endocrinology. 2012;28(7):529–532. doi: 10.3109/09513590.2011.650661.
    1. Mukhopadhyay P., Sankar T. B., Kyal A., Saha P. D. Oral hypoglyceamic glibenclamide: can it be a substitute to insulin in the management of gestational diabetes mellitus? A comparative study. Journal of South Asian Federation of Obstetrics and Gynaecology. 2012;4(1):28–31.
    1. Niromanesh S., Alavi A., Sharbaf F. R., Amjadi N., Moosavi S., Akbari S. Metformin compared with insulin in the management of gestational diabetes mellitus: a randomized clinical trial. Diabetes Research and Clinical Practice. 2012;98(3):422–429. doi: 10.1016/j.diabres.2012.09.031.
    1. Silva J. C., Pacheco C., Bizato J., de Souza B. V., Ribeiro T. E., Bertini A. M. Metformin compared with glyburide for the management of gestational diabetes. International Journal of Gynecology and Obstetrics. 2010;111(1):37–40. doi: 10.1016/j.ijgo.2010.04.028.
    1. Mesdaghinia E., Samimi M., Homaei Z., Saberi F., Moosavi S. G. A., Yaribakht M. Comparison of newborn outcomes in women with gestational diabetes mellitus treated with metformin or insulin: a randomised blinded trial. International Journal of Preventive Medicine. 2013;4(3):327–333.
    1. Spaulonci C. P., Bernardes L. S., Trindade T. C., Zugaib M., Francisco R. P. V. Randomized trial of metformin vs insulin in the management of gestational diabetes. American Journal of Obstetrics and Gynecology. 2013;209(1):34.e1–34.e7. doi: 10.1016/j.ajog.2013.03.022.
    1. Nicholson W. K., Wilson L. M., Witkop C. T., et al. Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes. Evidence Report/Technology Assessment. 2008;(162):1–96.
    1. Nankervis A., McIntyre H. D., Moses R. G., Ross G. P., Callaway L. K. Testing for gestational diabetes mellitus in Australia. Diabetes Care. 2013;36(5):p. e64. doi: 10.2337/dc12-2345.
    1. Behrashi M., Samimi M., Ghasemi T., Saberi F., Atoof F. Comparison of glibenclamide and insulin on neonatal outcomes in pregnant women with gestational diabetes. International Journal of Preventive Medicine. 2016;7(1):p. 88. doi: 10.4103/2008-7802.184502.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다